Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04587115 · ClinicalTrials.gov registry record · Early Phase 1
Reducing the Abuse Liability of Prescription Opioids
A Early Phase 1 study of Addiction, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT04587115 is a Early Phase 1 study of Addiction that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 15 participants, below the 692-participant average among 16 other Addiction trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04587115, a Early Phase 1 study of Addiction, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Opioid (commonly called narcotic) pain medicines are, after marijuana, the most commonly abused substances in the United States. Patients who take opioids for legitimate reasons may become addicted; for example, as many as 1 in 4 patients meet the criteria for current opioid dependence. It is very important that a way is found to provide pain relief while minimizing the addiction potential of these widely used pain medications. The study aim to find out if the use of another type of medication given in addition to an opioid will reduce the addiction potential of the opioid. The study is trying to find out if the ability of the opioid to relieve pain is changed when given with the other medication, and to see if the euphoric sensation or "liking" of the opioid pain medication is reduced when taken with the other medication.
Conditions Studied
Interventions
- DRUG Risperidone
- DRUG Oxycodone
- DRUG Ziprasidone
Study Locations (1)
Texas
- Westgate Pain Clinic - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-06-16 |
| Est. Completion | 2020-01-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04587115
The ClinicalTrials.gov registry entry for NCT04587115 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 692-participant average among 16 other Addiction trials with a reported enrollment target (98% lower). The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Addiction appearing as the primary indexed condition, and to 3 interventions - of which Risperidone is the first listed.
NCT04587115 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04587115 about?
NCT04587115 is a clinical study titled "Reducing the Abuse Liability of Prescription Opioids". Opioid (commonly called narcotic) pain medicines are, after marijuana, the most commonly abused substances in the United States. Patients who take opioids for legitimate reasons may become addicted; for example, as many as 1 in 4 patients meet the criteria for current opioid dependence. It is very i...
What is the current status of trial NCT04587115?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2017-06-16. Estimated completion is 2020-01-01.
What conditions does trial NCT04587115 study?
This clinical trial studies the following conditions: Addiction.
What interventions are being tested in trial NCT04587115?
The interventions under investigation include: Risperidone (DRUG), Oxycodone (DRUG), Ziprasidone (DRUG).
Who is sponsoring clinical trial NCT04587115?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04587115 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Addiction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Tolerability of Cannabidiol Among Persons With Opioid Use Disorder Receiving Methadone or Buprenorphine
COMPLETED · Early Phase 1
-
Semaglutide Therapy for Alcohol Reduction (STAR)
RECRUITING · Phase 2
-
Tdcs And cogNitive traininG cOmbined for AUD (TANGO)
RECRUITING · NA
-
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
RECRUITING
-
Behavioral and Functional Task Development, Implementation, and Testing
RECRUITING · NA
-
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.